Cynata Therapeutics Ltd
ASX:CYP

Watchlist Manager
Cynata Therapeutics Ltd Logo
Cynata Therapeutics Ltd
ASX:CYP
Watchlist
Price: 0.355 AUD 16.39%
Market Cap: 84.3m AUD

Wall Street
Price Targets

CYP Price Targets Summary
Cynata Therapeutics Ltd

There are no price targets for CYP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Cynata Therapeutics Ltd Competitors:
Price Targets
IVA
Inventiva SA
211% Upside
ELDN
Eledon Pharmaceuticals Inc
426% Upside
KALV
Kalvista Pharmaceuticals Inc
108% Upside
4593
Healios KK
154% Upside
MSB
Mesoblast Ltd
22% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
48% Upside
MRSN
Mersana Therapeutics Inc
18% Upside
IMDX
Insight Molecular Diagnostics Inc
8% Upside

Revenue
Forecast

Revenue Estimate
Cynata Therapeutics Ltd

For the last 13 years the compound annual growth rate for Cynata Therapeutics Ltd's revenue is -3%. The projected CAGR for the next 3 years is 123%.

-3%
Past Growth
123%
Estimated Growth
Estimates Accuracy
-86%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Cynata Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Cynata Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-60%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CYP's stock price target?
Not Available

CYP doesn't have any price targets made by Wall Street professionals.

What is Cynata Therapeutics Ltd's Revenue forecast?
Projected CAGR
123%

For the last 13 years the compound annual growth rate for Cynata Therapeutics Ltd's revenue is -3%. The projected CAGR for the next 3 years is 123%.

Back to Top